Item 9 Labs (INLB)
(Delayed Data from OTC)
$0.00 USD
0.00 (0.00%)
Updated Jun 10, 2024 12:19 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
INLB 0.00 0.00(0.00%)
Will INLB be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for INLB based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for INLB
Item 9 Labs Corp. (INLB) Reports Q3 Loss, Misses Revenue Estimates
MeiraGTx Holdings PLC (MGTX) Reports Q2 Loss, Tops Revenue Estimates
INLB: What are Zacks experts saying now?
Zacks Private Portfolio Services
OraSure Technologies (OSUR) Reports Break-Even Earnings for Q2
Item 9 Labs Corp. (INLB) Reports Q2 Loss, Lags Revenue Estimates
Other News for INLB
Bearish Sentiment Across The Cannabis Space - Check Full Movers For June 3, 2024
Bullish Monday For Marijuana Stocks - Target Group, Item 9 Labs Among Top Gainers
Bullish Tuesday For Marijuana Stocks - Elixinol Wellness, Item 9 Labs Among Top Gainers
Marijuana Stock Movers For April 17, 2024
Cannabis Stock Gainers And Losers From April 16, 2024